MITIE Group plc (MTO) — Investment Research Note

Executive summary

Mitie is the UK's leading technology-led Facilities Management, Transformation and Compliance company (84,000 colleagues, FY26 revenue £5.6bn, ~4.7% operating margin), delivering hard/soft services, project work and compliance to blue-chip public and private sector customers. The Group has delivered three consecutive years of double-digit revenue and operating profit growth (FY24 +11%, FY25 +13%, FY26 +11%), completed the transformative £350m Marlowe acquisition, and grown its pipeline to a record £31.7bn. The single most important valuation point today is that Mitie is under an agreed recommended cash acquisition by OCS Group at 218.5p per share cash (plus the 3.1p final FY26 dividend paid on 27 August 2026), unanimously recommended by the Board and expected to complete Q1 2027 2026-07-21 Rule 2.7; 2026-08-28 offer update.

Fair value estimate

Given the announced recommended cash offer, the primary valuation anchor is the deal itself, not standalone DCF.

• Deal-driven fair value: 218.5p per share in cash on completion (the 3.1p FY26 final dividend has already been paid). This values fully diluted equity at ~£3.1bn 2026-07-21 Rule 2.7.
• Standalone fair value (pre-deal reference): Applying ~11-13x FY26 EPS before other items of 13.6p to a UK support-services multiple (peer range for Serco/Rentokil/Compass ex-growth premium) would give ~150-175p per share, or ~£1,900-£2,200m market cap. FY26 free cash flow of £162m at a 12-14x FCF yield gives similar ~£1,950-£2,270m.
• Absolute upside vs current £2,588m market cap:
  • To 218.5p deal price: +4.5% absolute (~£116m to £2,704m market cap).
  • Downside if deal fails: potentially ~150p pre-bid VWAP, implying -28%.

Methodology: Announced cash bid, cross-checked against multiples-based standalone DCF. Blended weighted fair value (85% probability of deal closing × 218.5p + 15% × 155p standalone) = ~209p — precisely where the shares trade, reflecting a rational deal-arbitrage market.

Sector context

• ICB classification: Industrials — Industrial Goods and Services (Business Support Services). Confirmed.
• Mitie's profile relative to sector peers: growth well above sector average (FY26 organic growth 5.3% vs typical UK FM market growth 2-3%), operating margin (4.7%) in line with UK peers but below premium global FM players, and leverage (0.8x covenant) is conservative for the sector. Quality is above sector average given technology investment and Marlowe integration.
• Listed peers: Serco Group (SRP.L), Rentokil Initial (RTO.L), Compass Group (CPG.L), and privately-held ISS/Sodexo/CBRE GWS as international benchmarks. Marlowe (LON:MRL) was itself the target of a prior transformation.

Investment thesis (3 bullets)

1. Deal arbitrage with strong protections: OCS's 218.5p cash bid is unanimously recommended by the Mitie Board, Directors' irrevocables cover 1.2% and Oasis Management's 9.9% swap commitment ties in a further large shareholder; financing is committed via CD&R equity plus a bank syndicate; regulatory conditions (CMA, EU, NSIA) are being actively worked with expected completion Q1 2027 2026-07-21 Rule 2.7; 2026-08-28 financing update.
2. Operational momentum underpins the standalone case: Q1 FY27 revenue +10% to £1,406m with 4% organic growth, £1.6bn TCV wins/renewals in Q1 (up 33% yoy), record £32.5bn pipeline, and BBB investment-grade credit rating reaffirmed by DBRS Morningstar 2026-07-21 Q1 FY27 update. Marlowe integration is delivering early cost synergies (£7m in FY26; £30m targeted by FY28) plus a c.£700m ACV cross-sell pipeline.
3. Cash generation and returns: FY26 free cash flow £162m ahead of £120m guidance, leverage a conservative 1.2x (0.8x covenant), and £100m of share buybacks announced for FY27 alongside a 5% dividend increase 2026-06-04 FY26 results. Even if the deal were to fall away, the standalone business is well-capitalised and cash-generative.

Key risks (3 bullets)

1. Deal completion risk: The offer is subject to CMA, EU Merger Regulation and UK National Security Act clearances, and OCS has explicitly reserved the right to invoke Material Regulatory Conditions to lapse the deal if remedies proposed by regulators are "adverse to a material extent" 2026-07-21 Rule 2.7 Appendix I para 7. A CMA Phase 2 reference would give either party a right to walk away. If the deal fails, the shares would likely revert towards the pre-bid three-month VWAP of 159.3p, a ~24% drawdown.
2. Technical Services underperformance and margin risk: Q1 FY27 Technical Services revenue fell 5% (£577m vs £608m), still lapping FY26 contract losses, with the new management team only recently in place 2026-07-21 Q1 FY27 update. If contract wins do not offset losses at the run rate assumed, medium-term margin progression could be pressured. Additionally, the FY26 £50m increase in employer NIC required c.£35m of contractual recovery and £15m of MEI mitigation, with limited further cushion.
3. Under-performing PFI contract in Communities: One legacy Interserve PFI contract lost £8.4m in FY23, £3.9m in FY24, achieved break-even in FY26 but remains fragile; Communities also carries £26.5m of contract-specific provisions, including £10.8m against a single disputed contract that has been outstanding for years 2026-06-04 FY26 results Notes 10, 2. Continued execution slippage would erode reported earnings quality if the deal were to fail.

Operating leverage

Mitie is a labour-intensive services business — cost of sales is ~88% of revenue (£4,962m of £5,619m in FY26) and predominantly variable with front-line headcount 2026-06-04 FY26 income statement. Gross margin of ~11.7% and operating margin of 4.7% imply modest fixed-cost leverage. Corporate overheads of £58.9m are only ~1% of revenue, so incremental revenue does drop through at better-than-average incremental margin — management guided that MEIs generated £25m of savings in FY26, and the PRIO (Process Reimagination & Optimisation) agentic AI programme is targeted to exceed the £20-25m FY27 delivery cost over the medium term. However, the pockets of true operating leverage — Marlowe's compliance business (higher-margin, "evergreen" contracts), Facilities Transformation projects (average project size doubled to £300k), and data-centre M&E work — are still a small share of the mix. A 10-20% revenue beat above current expectations would likely translate to a 15-30% operating profit uplift, not the multi-x uplift the investor's strategy seeks. This is a moderate-leverage business, not a high-leverage one.

Value-trap signals

None identified in the current setup. The business shows growing revenue, growing operating profit, growing dividend, improving free cash flow and a credible integration path for a material acquisition. Two watch-points remain — the PFI contract-specific provisions in Communities and the previously loss-making telecoms infrastructure business (now break-even) — but neither is systemic. The takeover offer at a 44.7% premium to the undisturbed close and 17.7% above the all-time high closing price of 185.7p is prima facie evidence that a well-informed private-equity-backed strategic acquirer sees no structural discount 2026-07-21 Rule 2.7.

Earnings vs. expectations

Across the filings, Mitie's track record versus its own guidance is consistently strong:

• FY24 (Jun 2024 results): Delivered £210m operating profit versus prior guidance of "at least £190m" (raised in Jan 2024 from £160m at H1 FY24). Revenue £4,511m (+11%). Free cash £158m vs ">£100m" guidance. Beat.
• FY25 (Jun 2025 results): Delivered £234m operating profit versus guidance raised in Apr 2025 to "c.£230m" (up from previous "at least £190m"). Revenue £5,091m (+13%). Free cash £143m vs ">£100m" guidance. Beat.
• FY26 (Jun 2026 results): Delivered £264m operating profit versus guidance raised in Apr 2026 to "at least £260m" (from previous £190m+). Revenue £5,619m (+10.5%). Free cash £162m vs ">£120m" guidance. Beat.

Pattern: Mitie has beaten guidance and raised guidance intra-year in each of the last three financial years — a consistent, credible pattern of under-promise and over-deliver.

Conviction

Rating: 5 — very high.

Anchoring factors: (1) The fair value is anchored by an announced, unanimously-recommended, fully-financed cash offer at 218.5p — this is not a modelled estimate but a legally-binding transaction price; (2) the current share price (209p) is trading at a rational deal-arb discount to that price consistent with normal completion probability weighted against downside; (3) Mitie's own operational disclosure is clean, granular and consistent with a well-run business that has delivered on prior guidance three years running.

Limiting factors: (1) Deal completion is not certain — CMA and EU regulatory clearance carries residual risk of remedies that could allow OCS to walk; (2) the "standalone fair value" downside case is inherently a model estimate, but as the primary anchor is the deal price this is second-order.

Driver scoring rationale (brief)

The investor's strategy explicitly seeks (1) AI-receiver exposure, (2) valuation discipline (don't overpay), (3) operating leverage, and (4) downside protection. Against this test, Mitie is:

• AI receiver: Low. Mitie is an AI spender deploying agentic AI internally to optimise its cost base ("PRIO" programme, Microsoft Copilot, Azure ChatGPT integration). It has some data-centre exposure via JCA Engineering and fire & security systems for hyperscalers, but this is a modest fraction of revenue, not the dominant driver. Management markets AI heavily but the value capture flows primarily to the AI providers (Microsoft, Salesforce, etc.), not to Mitie's shareholders.
• Valuation: Fair. The takeover offer values Mitie at ~15x FY26 EPS before other items — a premium multiple for a UK FM company but not extreme, and the shares now trade at a small discount to the bid.
• Operating leverage: Low-medium. Labour-intensive services business with variable cost base.
• Downside protection: Moderate. Investment-grade balance sheet, but if deal fails, ~24% downside to the pre-bid VWAP.

The overwhelming issue: With only ~4.5% upside to the deal price and expected completion in Q1 2027, this is a deal arbitrage play, not a fit for a long-term AI-receiver / operating-leverage portfolio. The stock will be delisted if the deal completes.